Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is a joke, 65% of revenue paid out in attorneys fees.

You really need to do a lot of reading to own this stock if you can;t or won't then you should not be in it.

 

PDS as extracted from teh 8/31 and 11/30 10 Q's

 Condensed Statements of Operations

                      3 months         6months         Change
Revenues $ 1,500,000      20,933,000         19,433,000
Expenses 3,966,543          13,598,760         9,632,217

So you complain when 19.4 millionin revenues  have 9.6 mil in expenses but you were quite when 1.5 mil in revenues had 3.5 mil in expense

If I were to follwo you're train of thought  you would be suggesting that teh Q1 3.5 in expenses was the cost to acheive 1.5 mil in licenses.

Huh??????  And you still want to own this stock

OBVIOUSLY The 6 months expenses by PDS HAVE NO DIRECT RELATIONSHIP 

with the Same period REVENUES.

 

Only someone BORN YESTERDAY would even contimplate such nonsense.

Actually if you read further that PDS can paid TPL approximatelyt 

3 million in the first two Quarters to cover related licensing expenses.

THAT leaves a cost of  approx 11 miilion in the first 6 months for other business NOT RELATING TO TPL LICENSING.

 

Of course there is other activity for licenses not yet signed buut being actively pursued

and then there is the cost of TT&C for the J3 settlment/licensing that I expect is at last 8 million of the reamining amount.

 

 

 

 

 

 

 

 

 

 

Share
New Message
Please login to post a reply